Crinetics Pharmaceuticals Inc (CRNX) Insider Trading
- $45,793,090.74
- $62,774,813.12
- April 15, 2024
- Stephen F Betz
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 1, 2021 | Insider | 5,668 | $27.38 | Sell | $155,189.84 | |
| Nov. 8, 2021 | Insider | 3,900 | $28.42 | Sell | $110,838.00 | |
| Nov. 5, 2021 | Insider | 12,600 | $27.95 | Sell | $352,170.00 | |
| Nov. 1, 2021 | Director | 8,954 | $25.50 | Sell | $228,327.00 | |
| Nov. 1, 2021 | Insider | 5,668 | $24.79 | Sell | $140,509.72 | |
| Oct. 27, 2021 | Insider | 3,000 | $24.00 | Sell | $72,000.00 | |
| Oct. 25, 2021 | Major Shareholder | 1,200,000 | $19.80 | Buy | $23,760,000.00 | |
| Oct. 21, 2021 | Insider | 1,042 | $21.10 | Sell | $21,986.20 | |
| Sept. 8, 2021 | Director | 6,046 | $25.50 | Sell | $154,173.00 | |
| Sept. 7, 2021 | CEO | 30,000 | $25.00 | Sell | $750,000.00 | |
| July 26, 2021 | Director | 5,000 | $19.59 | Sell | $97,950.00 | |
| July 19, 2021 | Director | 5,000 | $19.50 | Sell | $97,500.00 | |
| July 12, 2021 | Director | 5,000 | $20.71 | Sell | $103,550.00 | |
| April 8, 2021 | Major Shareholder | 304,136 | $16.44 | Buy | $4,999,995.84 | |
| Dec. 2, 2020 | CEO | 1,000 | $12.60 | Buy | $12,600.00 | |
| July 15, 2020 | CEO | 17,500 | $15.30 | Sell | $267,750.00 | |
| April 17, 2020 | Major Shareholder | 84,598 | $15.40 | Sell | $1,302,809.20 | |
| April 15, 2020 | Major Shareholder | 215,810 | $15.50 | Sell | $3,345,055.00 | |
| April 7, 2020 | Major Shareholder | 6,115 | $14.20 | Sell | $86,833.00 | |
| April 3, 2020 | Major Shareholder | 300,000 | $13.80 | Sell | $4,140,000.00 | |
| March 9, 2020 | Major Shareholder | 528 | $19.50 | Sell | $10,296.00 | |
| Feb. 10, 2020 | Major Shareholder | 7,555 | $21.40 | Sell | $161,677.00 | |
| Feb. 7, 2020 | Major Shareholder | 5,905 | $22.00 | Sell | $129,910.00 | |
| Feb. 4, 2020 | Major Shareholder | 13,460 | $22.80 | Sell | $306,888.00 | |
| Jan. 31, 2020 | Major Shareholder | 5,400 | $21.70 | Sell | $117,180.00 | |
| Jan. 29, 2020 | Major Shareholder | 13,920 | $22.20 | Sell | $309,024.00 | |
| Dec. 16, 2019 | Director | 3,500 | $22.50 | Sell | $78,750.00 | |
| June 21, 2019 | Insider | 250,000 | $22.20 | Sell | $5,550,000.00 | |
| March 20, 2019 | Major Shareholder | 417,000 | $22.25 | Sell | $9,278,250.00 | |
| March 18, 2019 | Major Shareholder | 154,839 | $24.25 | Sell | $3,754,845.75 | |
| Jan. 22, 2019 | Major Shareholder | 262,153 | $21.88 | Sell | $5,735,907.64 | |
| July 20, 2018 | Director | 400,000 | $17.00 | Buy | $6,800,000.00 | |
| July 20, 2018 | Insider | 2,000 | $17.00 | Buy | $34,000.00 | |
| July 20, 2018 | Major Shareholder | 353,180 | $18.62 | Buy | $6,576,211.60 |
Insiders are both buying and selling Crinetics Pharmaceuticals Inc stock.
The insider traders at Crinetics Pharmaceuticals Inc are: Stephen F Betz, Vivo Capital Viii, Llc, Richard Scott Struthers, Matthew K Fust, Dana Pizzuti, Marc Wilson, Perceptive Advisors Llc, Ventures Iv L.P. 5Am, Alan Seth Krasner, Jeff E Knight, Ajay Madan, Stephanie Okey, Coelho Rogerio Vivaldi, Life Sciences Maste Perceptive, Vivo Capital Fund Viii, L.P., and Fust Matthew K
The most active insider trader at Crinetics Pharmaceuticals Inc is Stephen F Betz with 30 trades.
Ventures Iv L.P. 5Am has sold the most Crinetics Pharmaceuticals Inc stock with a total value of $20,590,753.39.
Perceptive Advisors Llc has bought the most Crinetics Pharmaceuticals Inc stock with a total value of $35,759,962.44.
The most recent insider trade for Crinetics Pharmaceuticals Inc was on April 15, 2024.
The single biggest insider buy for Crinetics Pharmaceuticals Inc was from Perceptive Advisors Llc with a total value of $23,760,000.00 on Oct. 25, 2021.
The single biggest insider sell for Crinetics Pharmaceuticals Inc was from Vivo Capital Fund Viii, L.P. with a total value of $9,278,250.00 on March 20, 2019.